Preparing the Skin for Laser Resurfacing
Opinions vary on whether pre-treating the skin improves outcomes of ablative laser procedures, but the literature does offer some guidance.

The value of pretreatment skincare protocols for ablative laser procedures has been debated for decades. In 1998, doctors at Massachusetts General Hospital Dermatology Laser Center published the results of a survey and literature review on the effect of pre- and postprocedure skincare protocols in laser skin resurfacing (Dermatologic Surgery, February). The two main reasons postulated for...


Preparing the Skin for Laser Resurfacing

The value of pretreatment skincare protocols for ablative laser procedures has been...

MedEsthetics Cover Profile July/August 2017

When Wendy Roberts, MD, applied to Sarah Lawrence College in New York, a career in...

Understanding Laser Contracts

Laser treatments have become a staple of the medical aes­thetics industry. More than 2...

e-Commerce Considerations

THE INTERNET HAS changed the way people shop. Today, consumers go online to purchase...


Biopelle antiaging eye treatment

The Tensage Growth Factor + Stem Cell Dual Eye Care Kit from Biopelle is a...

Safer sclerotherapy injections

The ergonomic SyrEase Syringe Adaptor from Syris Scientific allows providers...

Titanium and zinc oxide sun protection.

Epionce Daily Shield Lotion Tinted SPF 50 provides all skin types—including...

Antiaging Skin Care

Induction Therapies P.R.R. Protein Rich Retinol 1.0%, 4.0% and 8.0% feature...


Facebook Ad Leads
By Angela (Miller) Hamilton, Facebook Marketing Expert at ReachLocal With more than 1.71 billion active users on Facebook, social media advertising is an important way for medspas and medical practices to reach local consumers online. Most facilties have a company page and perhaps purchase a few...
Addressing Employee Tardiness
By Paul Edwards, CEO of CEDR HR Solutions There’s nothing more maddening than knowing your patients are due to arrive at your door at any moment, but because one or more of your employees STILL hasn’t shown up for work, you won’t be able to take the patients back right away. Despite the many...
Expert Consensus on Absorbable Facial Suspension Sutures

Absorbable facial suspension sutures made of poly-l-actic acid (PLLA) and poly-lactide-co-glycolide (PGLA) offer benefits to patients with moderate facial aging who require more correction than can be achieved with injectable soft tissue fillers, according to an evidence review of suture lift technologies published in the Journal of Drugs in Dermatology (July 2017).

A group of U.S.-based dermatologists and plastic surgeons convened to create an expert consensus on the use of a new-generation PLLA/PGLA absorbable suspension technology (Silhouette InstaLift). They performed a PubMed and Cochrane Library search of studies published between January 1, 2009 and April 30, 2016. The study review revealed that the introduction of absorbable PLLA/PGLA sutures (vs. non-absorbable polypropylene threads) reduced complications while offering longevity of results—1.5 to 2 years—and that patient selection and proper vector design are key factors in achieving optimal outcomes.

The consensus reached on ideal candidates for the procedure included: 35 to 65 years of age; good facial tissue quality and good pliability without excessive fibrosis and sun damage; sufficient skin thickness. The authors discouraged the use of...

Majority of sunscreens distributed by major US retailers meet AAD recommendations

Ariel E. Eber, MD, et al, from the University of Miami Miller School of Medicine, conducted a follow-up to a 2014 study that evaluated 472 sunscreens available at two major U.S. retailers (WalMart and Walgreens) to see if they met the American Academy of Dermatology’s recommendations.

Dr. Eber and colleagues found that, in 2017, more sunscreens complied with the AAD’s recommendations than in 2014. The recommendations, which were released following the U.S. FDA’s 2011 standardization of sunscreen labeling, include:

1. Sun protection factor (SPF) ≥30
2. broad-spectrum coverage
3. water resistant for 40 to 80 minutes

In the 2014 study by Yazdani, et al, only 34.5% of sunscreens sold at WalMart and 41.0% of sunscreens sold at Walgreens met all AAD recommendations. In January 2017, 65.3% of sunscreen at WalMart and 72.9% at Walgreens met all three recommendations. More than 80% of the sunscreens had SPF ≥30; more than 90% demonstrated broad-spectrum coverage per FDA regulations and more than 75% were water resistant for 40 to 80 minutes. The study was published in the Journal of the American Academy of Dermatology (August 2017).

Image copyright Getty Images

Valeant To Sell Obagi Medical Products

Valeant Pharmaceuticals has entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I. Valeant will use proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility. The transaction is expected to close in the second half of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals.

“The sale of Obagi marks additional progress in our efforts to streamline our operations and reduce debt,” said Joseph C. Papa, chairman and CEO of Valeant. “As we continue to transform Valeant, we will remain focused on the core businesses that will drive high value for our shareholders.”

Biologic Therapy Dupixent (Dupilumab) Approved For Atopic Dermatitis

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) Injection from Regeneron Pharmaceuticals, and Sanofi for the treatment of adults with moderate-to-severe atopic dermatitis (AD).

Dupixent is a human monoclonal antibody that is designed to specifically inhibit overactive signaling of two key proteins, IL-4 and IL-13, which are believed to be major drivers of the persistent underlying inflammation in AD. It comes in a pre-filled syringe and can be self-administered as a subcutaneous injection every other week after an initial loading dose and can be used... more »

AAD Commends FDA for Indoor Tanning Restrictions

The American Academy of Dermatology (AAD) applauds the U.S. Food and Drug Administration (FDA) for proposing new regulations governing indoor tanning, including an age restriction for minors under the age of 18 as well as a risk-acknowledgement form that all adults must sign before using indoor tanning devices.

According to the AAD, statistics show that millions of people tan indoors annually and the risk of developing melanoma increases by 59% for individuals exposed to UV radiation from indoor tanning—the risk increases with each use. If the FDA’s proposed rule becomes final,... more »

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.

The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.

The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »